Company intelligence / Profile preview
Wakamoto Pharmaceutical
- Ownership
- Private
- Employees
- ~403
- Development stage
- Other
Overview
Wakamoto Pharmaceutical has a long history in Japan as a pioneer in self-medication and gastrointestinal health. Its flagship product "Strong Wakamoto" is an OTC probiotic/enzyme supplement for digestive health. The company also develops and markets prescription ophthalmology drugs and recently entered into licensing agreements to bring intraocular lens products to Japan. Several of its products are approved and commercially available in Japan[2][3][5][7].
- Therapeutic areas
- OphthalmologyImmunologyInfectious Diseases
- Modalities
- Small moleculeProbioticsEnzyme-based therapy
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Wakamoto Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wakamoto Pharmaceutical.